In January 2022, Revelation Biosciences, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.978 USD | +3.00% | +9.92% | -87.34% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-87.34% | 3.14M | |
+44.99% | 56.65B | |
-7.24% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.08% | 26.75B | |
-21.49% | 19.03B | |
+1.05% | 12.28B | |
+23.54% | 12.26B | |
+27.10% | 12.04B |
- Stock Market
- Equities
- REVB Stock
- News Revelation Biosciences, Inc.
- Revelation Biosciences, Inc. announced that it has received $7.598001 million in funding